Ping An Biomedical announced a strategic cooperation agreement with Yuan Sheng Mei Yan Health Services targeting cumulative sales of RMB 500 million over three years. Yuan Sheng will serve as development partner for product distribution, market expansion, and terminal service implementation, while Ping An provides biotechnology products, technical expertise, and R&D support. The partnership aims to accelerate commercialization by leveraging Yuan Sheng's health management platform, wellness services, and high-end customer network. Ping An expects the collaboration to broaden revenue opportunities and support regional expansion through Yuan Sheng's government-enterprise collaborations in Beijing's Huairou District and Shenyang. Shares of Ping An Biomedical dropped 18.26% to $0.12.
Ping An Biomedical Co., Ltd.Partnership targeting RMB 500 million sales over three years, expanding distribution and customer access.
Yuan Sheng gains exclusive distribution rights and access to Ping An's biotech products, expanding its service offerings.